CoChat

Acute effect of orlistat on post‐prandial lipaemia and free fatty acids in overweight patients with Type 2 diabetes mellitus

Tan, K. C. B., Tso, A. W. K., Tam, S. C. F., Pang, R. W. C., Lam, K. S. L. · 2002 · Diabetic Medicine
Cited by 41

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Aims Post‐prandial lipaemia is prolonged and exaggerated in patients with Type 2 diabetes mellitus, with an accumulation of atherogenic triglyceride‐rich lipoprotein remnants. We postulate that orlistat, a gastrointestinal lipase inhibitor, may cause changes in post‐prandial lipoprotein metabolism by reducing dietary triglyceride absorption. Methods The acute effect of a single dose of 120 mg orlistat on post‐prandial glucose, lipids, remnant lipoproteins and free fatty acids (FFA) was evaluated in a randomized, double‐blind, placebo‐controlled cross‐over study of 63 overweight patients with Type 2 diabetes mellitus (body mass index 30.4 ± 3.8 kg/m 2). Either a single dose of orlistat or placebo was given before a standard mixed meal containing 70 g of fat and plasma triglyceride (TG), remnant‐like particles cholesterol (RLP‐C) and FFA were sampled at 2‐h intervals for 8 h. RLP‐C was measured by an immunoseparation assay and FFA by an enzymatic colorimetric method. Results The concentrations of plasma TG (P < 0.0001), RLP‐C (P = 0.003), and FFA (P < 0.0001) were significantly lower at 2 h after orlistat compared with placebo. Both plasma RLP‐C (P = 0.04) and FFA (P < 0.0001) remained lower after orlistat than placebo at 4 h. The incremental area under the curve (iAUC) above baseline fasting level for both TG and RLP‐C was significantly more reduced after orlistat than placebo (iAUC‐TG 5.8 (3.7–8.2) mmol/l × h−1 vs. 5.7 (4.1–10.9), respectively, P = 0.04; iAUC‐RLP‐C: 0.53 (0.23–1.04) mmol/l × h−1 vs. 0.56 (0.35–1.40), respectively, P = 0.02). The test meal was well tolerated by all subjects, with only three subjects reporting faecal urgency after orlistat. Conclusions Orlistat has a beneficial effect on post‐prandial lipaemia in overweight Type 2 diabetic patients and lowers plasma TG, RLP‐C and FFA in the early post‐prandial period. Diabet. Med. 19, 944–948 (2002)

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1464-5491.2002.00823.x

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 41

Metadata

Authors
Tan, K. C. B., Tso, A. W. K., Tam, S. C. F., Pang, R. W. C., & Lam, K. S. L.
Venue
Diabetic Medicine
Publisher
Wiley
Published
2002-11
Volume
19
Issue
11
Pages
944-948
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W2053114173
Cited by
41
References
5
FWCI
2.80
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Acute effect of orlistat on post‐prandial lipaemia and free fatty acids in overweight patients with Type 2 diabetes mellitus. https://app.cochat.ai/papers/10.1046/j.1464-5491.2002.00823.x
The paper
Tan, K. C. B., Tso, A. W. K., Tam, S. C. F., Pang, R. W. C., & Lam, K. S. L. (2002). Acute effect of orlistat on post‐prandial lipaemia and free fatty acids in overweight patients with Type 2 diabetes mellitus. Diabetic Medicine. https://doi.org/10.1046/j.1464-5491.2002.00823.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.